rs1042522
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The effect of rs1042522 C>G polymorphism on Wilms tumor prevalence was analyzed using logistic regression models.
|
30610160 |
2019 |
rs11655237
|
|
|
0.020 |
GeneticVariation |
BEFREE |
These data could be useful for reinforcing our understanding of the potential contribution of LINC00673 rs11655237 C>T to Wilms tumor susceptibility.
|
31657076 |
2019 |
rs11655237
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In conclusion, we failed to find any association between the LINC00673 rs11655237 C>T polymorphism and WT risk.
|
31257678 |
2019 |
rs1042522
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Overall, our result suggested a lack of association between the <i>TP53</i> gene Arg72Pro polymorphism and Wilms' tumor.
|
28260929 |
2017 |
rs16754
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia.
|
26224397 |
2015 |
rs16754
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The genetic variant rs16754 of Wilms tumor gene 1 (WT1) has recently been described as an independent prognostic factor in AML patients.
|
25932444 |
2015 |
rs376882637
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our findings suggest that TRIP13 c.1060C>T mutation may be infrequent in Pakistani WT cases.
|
31574018 |
2020 |
rs1059111
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The association between rs11994014 G>A or rs1059111 A>T polymorphisms and Wilms' tumor susceptibility did not reach statistical significance.
|
31057612 |
2019 |
rs113488022
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In summary, we demonstrate that BRA</span>F V600E mutations are not entirely restricted to typical MA, as they may be seen in MAs showing mitotic activity along with a subset of epithelial-predominant WTs in adults and children that have foci which overlap morphologically with MA.
|
31192863 |
2019 |
rs11994014
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The association between rs11994014 G>A or rs1059111 A>T polymorphisms and Wilms' tumor susceptibility did not reach statistical significance.
|
31057612 |
2019 |
rs121913377
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In summary, we demonstrate that BRA</span>F V600E mutations are not entirely restricted to typical MA, as they may be seen in MAs showing mitotic activity along with a subset of epithelial-predominant WTs in adults and children that have foci which overlap morphologically with MA.
|
31192863 |
2019 |
rs12587
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Stratification analysis revealed that rs12587 GT/TT was associated with Wilms tumor risk in children >18 months old (adjusted OR=1.39, 95% CI=1.02-1.89, <i>P</i>=0.037).
|
30860980 |
2019 |
rs2168101
|
|
|
0.010 |
GeneticVariation |
BEFREE |
These results suggest that <i>LMO1</i> gene rs2168101 G>T polymorphism may help prevent Wilms tumor, but this conclusion should be verified in other populations and additional studies.
|
31205537 |
2019 |
rs28647582
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our study suggested that PHOX2B rs28647582 T>C was weakly associated with Wilms tumor susceptibility.
|
31652452 |
2019 |
rs2979704
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our findings suggested that the <i>NEFL</i> rs2979704 T>C polymorphism may be associated with Wilms' tumor susceptibility in the Chinese population.
|
31057612 |
2019 |
rs57961569
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Interestingly, in the stratification analysis, the rs57961569 was found to be associated with decreased Wilms tumor susceptibility in the children older than 18 months (AOR = 0.65, 95% CI = 0.42-1.00, P = .050).
|
31343784 |
2019 |
rs6581658
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We carried out the first four-center case-control study with 355 patients and 1070 controls to assess the association of HMGA2 polymorphisms (rs6581658 A>G, rs8756 A>C, and rs968697 T>C) with Wilms tumor risk.
|
31746066 |
2019 |
rs8173
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In conclusion, our findings indicated that the <i>AURKA</i> rs8173 G>C polymorphism was associated with decreased Wilms tumor risk in Chinese children.
|
31636670 |
2019 |
rs8756
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We carried out the first four-center case-control study with 355 patients and 1070 controls to assess the association of HMGA2 polymorphisms (rs6581658 A>G, rs8756 A>C, and rs968697 T>C) with Wilms tumor risk.
|
31746066 |
2019 |
rs968697
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We firstly demonstrated that rs6581658 A>G, rs8756 A>C, and rs968697 T>C could not impact Wilms tumor risk, respectively.
|
31746066 |
2019 |
rs1052133
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Significant associations with Wilms tumor susceptibility were shown for hOGG1 rs1052133 (dominant: adjusted OR = 0.66, 95% CI = 0.45-0.96, P = .030), FEN1 rs174538 (dominant: adjusted OR = 0.66, 95% CI = 0.45-0.95, P = .027; recessive: adjusted OR = 0.54, 95% CI = 0.32-0.93 P = .027), and FEN1 rs4246215 (dominant: adjusted OR = 0.55, 95% CI = 0.38-0.80, P = .002) polymorphisms.
|
29937070 |
2018 |
rs174538
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Significant associations with Wilms tumor susceptibility were shown for hOGG1 rs1052133 (dominant: adjusted OR = 0.66, 95% CI = 0.45-0.96, P = .030), FEN1 rs174538 (dominant: adjusted OR = 0.66, 95% CI = 0.45-0.95, P = .027; recessive: adjusted OR = 0.54, 95% CI = 0.32-0.93 P = .027), and FEN1 rs4246215 (dominant: adjusted OR = 0.55, 95% CI = 0.38-0.80, P = .002) polymorphisms.
|
29937070 |
2018 |
rs314276
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In summary, these results indicated that the LIN28B gene rs314276 C>A polymorphism alone and three combined polymorphisms may be able to modify WT susceptibility in Southern Chinese children.
|
28301057 |
2018 |
rs3810366
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The XPD rs3810366 polymorphism significantly enhanced Wilms tumor risk (dominant model: adjusted OR = 2.12, 95% CI = 1.26-3.57).
|
30161024 |
2018 |
rs4246215
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Significant associations with Wilms tumor susceptibility were shown for hOGG1 rs1052133 (dominant: adjusted OR = 0.66, 95% CI = 0.45-0.96, P = .030), FEN1 rs174538 (dominant: adjusted OR = 0.66, 95% CI = 0.45-0.95, P = .027; recessive: adjusted OR = 0.54, 95% CI = 0.32-0.93 P = .027), and FEN1 rs4246215 (dominant: adjusted OR = 0.55, 95% CI = 0.38-0.80, P = .002) polymorphisms.
|
29937070 |
2018 |